Achilles Therapeutics Plc (ACHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 18,092 | 18,553 | 22,834 | 16,034 | 20,546 |
| Operating Income | -18,092 | -18,553 | -22,834 | -16,034 | -20,546 |
| Other Income | 1,212 | 1,091 | -1,181 | 3,599 | 3,271 |
| Pre-tax Income | -16,880 | -17,462 | -24,015 | -12,435 | -17,275 |
| Income Tax | -34 | 44 | 41 | 41 | 14 |
| Net Income Continuous | -16,846 | -17,506 | -24,056 | -12,476 | -17,289 |
| Net Income | $-16,846 | $-17,506 | $-24,056 | $-12,476 | $-17,289 |
| EPS Basic Total Ops | -0.42 | -0.44 | -0.61 | -0.32 | -0.44 |
| EPS Basic Continuous Ops | -0.42 | -0.44 | -0.61 | -0.32 | -0.44 |
| EPS Diluted Total Ops | -0.42 | -0.44 | -0.61 | -0.32 | -0.44 |
| EPS Diluted Continuous Ops | -0.42 | -0.44 | -0.61 | -0.32 | -0.44 |
| EPS Diluted Before Non-Recurring Items | -0.42 | -0.44 | -0.61 | N/A | N/A |
| EBITDA(a) | $-16,839 | $-17,445 | $-22,003 | $-15,144 | $-19,630 |